vidarabine has been researched along with laurocapram in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, DC; Durrani, MJ; Higuchi, WI; Imanidis, G; Kim, SW; Komada, F; Miyajima, M; Okano, T; Shannon, WM | 1 |
| Xu, HN | 1 |
| Baker, DC; Flynn, GL; Fox, JL; Higuchi, WI; Ho, NF; Kumar, SD; Shannon, WM; Sugibayashi, K; Vaidyanathan, R; Westbrook, L | 1 |
3 other study(ies) available for vidarabine and laurocapram
| Article | Year |
|---|---|
Design of 9-beta-D-arabinofuranosyladenine (ara-A) transdermal delivery system for animal studies: regulation of drug concentration in vivo.
Topics: Administration, Cutaneous; Animals; Arabinonucleosides; Azepines; Chromatography, Thin Layer; In Vitro Techniques; Mice; Mice, Hairless; Models, Biological; Skin Absorption; Vidarabine | 1991 |
[Continuous effect of azone pretreatment on permeability of antivirotic Ara-ADA through hairless mouse skin].
Topics: Administration, Cutaneous; Animals; Antiviral Agents; Azepines; Mice; Mice, Hairless; Permeability; Skin Absorption; Vidarabine | 1989 |
Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Topics: Acyclovir; Administration, Topical; Animals; Antiviral Agents; Azepines; Chromatography, Thin Layer; Diffusion; Herpes Simplex; Mice; Mice, Hairless; Permeability; Skin Absorption; Time Factors; Vidarabine | 1985 |